BlossomHill at Guggenheim: a macrocyclic push in cancer drugs

🌐 Investing.com (Cyprus) —
BlossomHill at Guggenheim: a macrocyclic push in cancer drugs

AI Summary

BlossomHill presented at Guggenheim on advancing macrocyclic approaches in cancer drug development. The headline points to oncology research, but provides no details on clinical results, funding, or partnerships.

Health BlossomHill Guggenheim cancer drugs macrocyclic compounds drug development oncology

Read original source →